TCF19 and nonpapillary renal cell carcinoma: Finally, we investigated whether TCF19 has an effect on the tumorigenic capacity of ccRCC cells in vivo, 786‐O cells were subcutaneously injected into BALB/c nude mice and treated with control siRNA (Ne‐siRNA), and TCF19‐siRNA in vivo siRNA delivery as indicated (Figure S12A).